| Literature DB >> 31204383 |
Fanjie Zeng1,2, Cong Chen3, Xiangyu Chen1, Lei Zhang1, Minghua Liu1.
Abstract
BACKGROUND The aim of this study was to assess the effects of a new treatment strategy for envenomation that consists of multiple small incisions and negative-pressure wound therapy (NPWT) on injured limb swelling and systemic inflammatory reaction. MATERIAL AND METHODS This was a prospective randomized controlled trial on snakebite envenomation. The enrolled patients were randomly divided into 2 groups: an observation group and a control group. The traditional comprehensive treatment was administered in both groups, but the observation group also received combined treatment with multiple small incisions and NPWT. Reduction in limb swelling, mean admission duration, complication rate, and changes in the levels of relevant cytokines were recorded and compared between the 2 groups. RESULTS The mean duration of hospital stay was significantly lower in the observation group than in the control group (5.44±0.89 days vs. 7.71±1.70 days). The complication rate and IL-6 concentration were significantly lower in the observation group than in the control group. CONCLUSIONS Multiple small incisions combined with NPWT proved effective for controlling the release of inflammatory cytokines and accelerating the relief of systemic inflammatory reaction. As a consequence, the complication rate decreased. Therefore, our new treatment strategy is safe and effective.Entities:
Year: 2019 PMID: 31204383 PMCID: PMC6592139 DOI: 10.12659/MSM.913579
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Six incisions were divided into 2 lines, 3 incisions in each line, 1.5 cm in length, 1 cm interval between each incision, 2 cm in-line spacing.
Comparison of two groups’ age, gender ratio, injured area, admission time after injury and Downey grading.
| Group | Cases | Age (y.o) | Gender ratio (Male/Female) | Injured area Upper extremity/lower extremity | Admission time after injury(h) | Downey grading (2/3) |
|---|---|---|---|---|---|---|
| Observation | 25 | 49.76±15.18 | 17/8 | 5/20 | 17.32±10.22 | 12/13 |
| Control | 25 | 51.62±15.93 | 16/9 | 8/17 | 16.79±13.61 | 14/11 |
| χ2 or t | t=0.403 | χ2=0.089 | χ2=0.936 | t=−0.153 | χ2=0.321 | |
| 0.689 | 0.765 | 0.333 | 0.879 | 0.571 |
Figure 2Variation tendency of the circumference difference between the injured limb and the healthy limb. (A) Changes of distal limb circumference difference. (B) Changes of middle limb circumference difference. (C) Changes of proximal limb circumference difference. a P<0.05, compared with the control group.
Admission days (χ̄±s, d).
| Group | Case | The shortest admission days (d) | The longest admission days (d) | The mean admission days (d) |
|---|---|---|---|---|
| Observation | 25 | 4 | 7 | 5.44±0.89 |
| Control | 25 | 5 | 12 | 7.71±1.70 |
| t=5.70 | ||||
Comparison of IL-6, TNF-α, IL-10, Endocan concentration changes in each time point between the two groups (pg/mL, χ̄±s).
| Group | 0 h | 6 h | 12 h | 24 h | 48 h | 72 h | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| IL-6 | Observation | 21.61±12.42 | 14.82±7.69 | 7.16±2.79 | 4.22±1.48 | 2.36±1.14 | 0.83±0.53 | <0.001 | <0.001 | 0.032 |
| Control | 21.76±15.97 | 16.99±10.34 | 12.46±6.27 | 9.10±4.26 | 5.93±3.02 | 3.42±2.00 | ||||
| TNF-α | Observation | 477.11±300.9 | 289.20±168.9 | 168.91±96.9 | 106.44±62.0 | 50.16±32.6 | 26.38±20.7 | <0.001 | <0.001 | 0.147 |
| Control | 466.58±309.9 | 389.14±288.8 | 289.45±219.5 | 214.85±154.5 | 118.62±62.7 | 54.55±27.6 | ||||
| IL-10 | Observation | 202.44±103.8 | 124.75±74.5 | 80.58±58.0 | 38.40±25.4 | 23.99±15.8 | 13.48±7.6 | <0.001 | <0.001 | 0.158 |
| Control | 238.68±165.9 | 161.11±108.8 | 112.27±80.0 | 61.61±45.1 | 34.85±30.1 | 17.81±12.8 | ||||
| Endocan | Observation | 2.63±1.79 | 3.35±1.76 | 4.06±1.43 | 4.21±1.24 | 3.89±1.20 | 3.30±1.15 | <0.001 | <0.001 | 0.468 |
| Control | 2.72±1.07 | 3.63±1.42 | 4.02±1.19 | 3.86±0.96 | 3.33±0.99 | 2.41±0.92 |
P1 – P value for Mauchly’s Test of sphericity; P2 – P value for tests of Within-Subjects Effects; P3 – P value for tests of Between-Subjects Effects.
The unit of measurement of Endocan is ng/mL.